Table 1.
Baseline Characteristics of the ovarian cancer patients enrolled in the study.
| Charateristics | Total (N = 991) |
|---|---|
| Age[median (range),years] | 55 (23-83) |
| ≤55 | 521 |
| >55 | 470 |
| Menopause | |
| Yes | 581 |
| No | 410 |
| FIGO stage | |
| I | 55 |
| II | 84 |
| III | 682 |
| IV | 170 |
| Family history of cancer | |
| Yes | 327 |
| No | 664 |
| Residual disease | |
| ≤1cm | 859 |
| >1cm | 132 |
| Histology | |
| Serous | 829 |
| Other | 162 |
| Grade | |
| Well | 376 |
| Moderate | 233 |
| Poor | 275 |
| Unknown | 107 |
| Lymph node status | |
| Positive | 548 |
| Negative | 443 |
| CA125 at diagnosis | 846.45 (270.48-2062.10) |
| ≤35 U/ml | 51 |
| >35 U/ml | 940 |
| Platelet (109/L) | 267.00 (207.00-345.00) |
| Neutrophil (109/L) | 4.40 (3.30-5.73) |
| Lymphocyte (109/L) | 1.40 (1.10-1.80) |
| Monocyte (109/L) | 0.50 (0.40-0.60) |
| NLR | 3.05 (2.15-4.43) |
| LMR | 3.00 (2.17-4.21) |
| PLR | 182.49 (128.67-267.04) |
| SII | 797.29 (489.19-1419.68) |
| PNR | 43.61 (30.61-64.44) |